Search

everythinglearnresearchcommunity

for

Search:↓

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

Tannic acid helps wounds heal faster in rats by activating certain cell signals and reducing inflammation.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Deoxycholic acid is effective for reducing chin fat but can cause side effects and serious complications, so careful patient evaluation is needed.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Hair loss in Rhesus macaques may be caused by a skin allergy-related condition.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Tailor treatments for vitiligo to patient needs for best results.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Older women face various skin issues like dryness and thinning, and treatments are available but can have side effects; proper skin care and legal health decisions are important.

Thermoresponsive nanogels show promise for delivering medicine through the skin but need more safety testing and regulatory approval before clinical use.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

Lichen Planopilaris in teens is rare, often misdiagnosed, and responds well to steroids.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

A 10-year-old girl with Fox Fordyce disease improved with treatment, suggesting the disease can occur before puberty and might be underdiagnosed in young girls.

Oral retinoids may help some patients with hard-to-treat lichen planopilaris, but more research is needed.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.